Nykredit A S purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the second quarter, HoldingsChannel.com reports. The firm purchased 56,584 shares of the semiconductor company’s stock, valued at approximately $25,240,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. AGH Wealth Advisors LLC boosted its position in Synopsys by 4.4% in the 1st quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company’s stock valued at $226,000 after buying an additional 24 shares during the last quarter. Hardy Reed LLC grew its stake in shares of Synopsys by 0.8% during the fourth quarter. Hardy Reed LLC now owns 3,309 shares of the semiconductor company’s stock valued at $1,554,000 after acquiring an additional 25 shares in the last quarter. Annis Gardner Whiting Capital Advisors LLC increased its position in shares of Synopsys by 16.9% during the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 180 shares of the semiconductor company’s stock worth $85,000 after acquiring an additional 26 shares during the last quarter. MCF Advisors LLC increased its position in shares of Synopsys by 17.8% during the fourth quarter. MCF Advisors LLC now owns 172 shares of the semiconductor company’s stock worth $81,000 after acquiring an additional 26 shares during the last quarter. Finally, Diversify Wealth Management LLC lifted its stake in shares of Synopsys by 1.2% in the fourth quarter. Diversify Wealth Management LLC now owns 2,213 shares of the semiconductor company’s stock worth $1,133,000 after acquiring an additional 27 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Stock Up 0.1%
Shares of Synopsys stock opened at $416.31 on Friday. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. The firm has a market cap of $79.78 billion, a P/E ratio of 73.55, a P/E/G ratio of 2.28 and a beta of 1.23. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $615.79. The business has a 50-day moving average price of $413.48 and a 200 day moving average price of $439.79.
Insider Activity at Synopsys
In related news, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Aart de Geus sold 24,641 shares of Synopsys stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total transaction of $10,335,421.04. Following the completion of the transaction, the insider directly owned 120,443 shares of the company’s stock, valued at approximately $50,518,611.92. This represents a 16.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 92,638 shares of company stock valued at $40,747,732. Corporate insiders own 0.56% of the company’s stock.
Analyst Upgrades and Downgrades
SNPS has been the subject of a number of analyst reports. Stifel Nicolaus increased their price target on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Bank of America upped their target price on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. KeyCorp reiterated an “overweight” rating on shares of Synopsys in a research note on Wednesday, August 19th. Citigroup raised their price target on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, Berenberg Bank set a $633.00 price target on shares of Synopsys in a research note on Wednesday, May 27th. Twelve research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $561.28.
Read Our Latest Research Report on Synopsys
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
